SANGAMO THERAPEUTICS, INC (SGMO) › Net IncomeSANGAMO THERAPEUTICS, INC (SGMO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$18.59M2010: -$24.85M2011: -$35.75M2012: -$22.26M2013: -$26.62M2014: -$26.42M2015: -$40.70M2016: -$71.66M2017: -$54.57M2018: -$68.33M2019: -$95.19M2020: -$121.00M2021: -$178.29M2022: -$192.28M2023: -$257.83M2024: -$97.94M2025: -$122.93M-$122.93M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$122.93M-25.5%2024-$97.94M+62.0%2023-$257.83M-34.1%2022-$192.28M-7.8%2021-$178.29M-47.3%2020-$121.00M-27.1%2019-$95.19M-39.3%2018-$68.33M-25.2%2017-$54.57M+23.8%2016-$71.66M-76.1%2015-$40.70M-54.1%2014-$26.42M+0.8%2013-$26.62M-19.6%2012-$22.26M+37.7%2011-$35.75M-43.8%2010-$24.85M-33.7%2009-$18.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share